Semi-Annual Statement Of Income

Kringle Pharma,Inc. - Filing #7592098

Concept 2021-10-01 to
2022-06-30
2020-10-01 to
2021-06-30
Semi-annual statement of income
Statement of income
Net sales
112,068,000 JPY
117,825,000 JPY
Cost of sales
JPY
JPY
Ordinary profit (loss)
-305,721,000 JPY
-245,177,000 JPY
Gross profit (loss)
112,068,000 JPY
117,825,000 JPY
Selling, general and administrative expenses
495,175,000 JPY
422,691,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-305,721,000 JPY
-245,177,000 JPY
Operating profit (loss)
-383,107,000 JPY
-304,865,000 JPY
Income taxes - current
1,117,000 JPY
1,117,000 JPY
Non-operating income
85,774,000 JPY
82,578,000 JPY
Non-operating income
Income taxes
1,117,000 JPY
1,117,000 JPY
Non-operating expenses
8,387,000 JPY
22,890,000 JPY
Profit (loss)
-306,838,000 JPY
-246,295,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.